ArticleMolecular and clinical oncology2022

Assessment of prognostic factors in previously treated Japanese patients with metastatic renal cell carcinoma who received nivolumab: An observational multi-institute study.

Toshiki Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.